Huadong Medicine Co Ltd (000963) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Huadong Medicine Co Ltd (000963) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥155.98 Million ≈ $22.82 Million USD) by net assets (CN¥24.50 Billion ≈ $3.58 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Huadong Medicine Co Ltd (000963) market capitalisation for the company's overall valuation and market capitalisation.
Huadong Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Huadong Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Huadong Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huadong Medicine Co Ltd ranked by their cash flow conversion efficiency. Explore Huadong Medicine Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sibanye Stillwater Limited
F:47VS
|
0.096x |
|
Osisko Gold Ro
TO:OR
|
0.059x |
|
Changjiang Securities Co Ltd
SHE:000783
|
0.350x |
|
Cleveland-Cliffs Inc
NYSE:CLF
|
0.040x |
|
BlueFocus Communication Group
SHE:300058
|
0.064x |
|
Nemetschek AG O.N.
XETRA:NEM
|
0.028x |
|
Zoomlion Heavy Industry Science and Technology Co Ltd
SHE:000157
|
0.004x |
|
Amdocs Ltd
NASDAQ:DOX
|
0.064x |
Annual Cash Flow Conversion Efficiency for Huadong Medicine Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Huadong Medicine Co Ltd from 1998 to 2024. View current stock price of Huadong Medicine Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥23.56 Billion ≈ $3.45 Billion |
CN¥3.75 Billion ≈ $548.59 Million |
0.159x | -12.61% |
| 2023-12-31 | CN¥21.58 Billion ≈ $3.16 Billion |
CN¥3.93 Billion ≈ $574.97 Million |
0.182x | +46.58% |
| 2022-12-31 | CN¥19.18 Billion ≈ $2.81 Billion |
CN¥2.38 Billion ≈ $348.54 Million |
0.124x | -33.62% |
| 2021-12-31 | CN¥16.94 Billion ≈ $2.48 Billion |
CN¥3.17 Billion ≈ $463.84 Million |
0.187x | -16.75% |
| 2020-12-31 | CN¥15.18 Billion ≈ $2.22 Billion |
CN¥3.41 Billion ≈ $499.20 Million |
0.225x | +44.46% |
| 2019-12-31 | CN¥12.87 Billion ≈ $1.88 Billion |
CN¥2.00 Billion ≈ $292.91 Million |
0.156x | -20.47% |
| 2018-12-31 | CN¥10.43 Billion ≈ $1.53 Billion |
CN¥2.04 Billion ≈ $298.44 Million |
0.196x | +3.74% |
| 2017-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
CN¥1.66 Billion ≈ $243.07 Million |
0.189x | +6.99% |
| 2016-12-31 | CN¥7.64 Billion ≈ $1.12 Billion |
CN¥1.35 Billion ≈ $197.10 Million |
0.176x | -13.19% |
| 2015-12-31 | CN¥3.24 Billion ≈ $474.60 Million |
CN¥658.54 Million ≈ $96.36 Million |
0.203x | -30.97% |
| 2014-12-31 | CN¥2.52 Billion ≈ $368.56 Million |
CN¥740.85 Million ≈ $108.41 Million |
0.294x | +85.94% |
| 2013-12-31 | CN¥3.02 Billion ≈ $441.21 Million |
CN¥476.98 Million ≈ $69.80 Million |
0.158x | -42.36% |
| 2012-12-31 | CN¥2.34 Billion ≈ $342.72 Million |
CN¥642.73 Million ≈ $94.05 Million |
0.274x | +2954.34% |
| 2011-12-31 | CN¥1.79 Billion ≈ $262.60 Million |
CN¥16.12 Million ≈ $2.36 Million |
0.009x | +143.20% |
| 2010-12-31 | CN¥1.35 Billion ≈ $196.94 Million |
CN¥-27.99 Million ≈ $-4.10 Million |
-0.021x | -104.74% |
| 2009-12-31 | CN¥1.29 Billion ≈ $189.31 Million |
CN¥567.94 Million ≈ $83.11 Million |
0.439x | +13.71% |
| 2008-12-31 | CN¥892.80 Million ≈ $130.64 Million |
CN¥344.69 Million ≈ $50.44 Million |
0.386x | -0.61% |
| 2007-12-31 | CN¥684.27 Million ≈ $100.13 Million |
CN¥265.79 Million ≈ $38.89 Million |
0.388x | +393.01% |
| 2006-12-31 | CN¥728.30 Million ≈ $106.57 Million |
CN¥57.38 Million ≈ $8.40 Million |
0.079x | -73.38% |
| 2005-12-31 | CN¥686.99 Million ≈ $100.53 Million |
CN¥203.33 Million ≈ $29.75 Million |
0.296x | +1435.72% |
| 2004-12-31 | CN¥648.91 Million ≈ $94.96 Million |
CN¥12.51 Million ≈ $1.83 Million |
0.019x | -86.42% |
| 2003-12-31 | CN¥637.95 Million ≈ $93.35 Million |
CN¥90.54 Million ≈ $13.25 Million |
0.142x | +260.25% |
| 2002-12-31 | CN¥607.81 Million ≈ $88.94 Million |
CN¥23.94 Million ≈ $3.50 Million |
0.039x | -79.24% |
| 2001-12-31 | CN¥578.05 Million ≈ $84.59 Million |
CN¥109.67 Million ≈ $16.05 Million |
0.190x | +400.09% |
| 2000-12-31 | CN¥516.34 Million ≈ $75.56 Million |
CN¥19.59 Million ≈ $2.87 Million |
0.038x | -66.12% |
| 1999-12-31 | CN¥502.91 Million ≈ $73.59 Million |
CN¥56.32 Million ≈ $8.24 Million |
0.112x | +5.70% |
| 1998-12-31 | CN¥224.63 Million ≈ $32.87 Million |
CN¥23.80 Million ≈ $3.48 Million |
0.106x | -- |
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more